Summary
CVS Health Corporation (CVS) filed an 8-K on July 17, 2015, to report the entry into a material definitive agreement for the issuance and sale of senior notes. The company successfully raised a substantial amount of capital through this offering, totaling approximately $14.81 billion after deducting underwriting discounts and estimated expenses. This significant debt issuance comprised notes with various maturities, ranging from 2018 to 2045, and interest rates between 1.900% and 5.125%. The proceeds from this offering are expected to support the company's ongoing operations and strategic initiatives. The filing highlights the company's access to capital markets and its proactive approach to managing its financing structure.
Key Highlights
- 1CVS Health entered into an Underwriting Agreement on July 13, 2015, for a significant senior notes offering.
- 2The total aggregate principal amount of notes sold was $15.25 billion.
- 3Net proceeds to the company are approximately $14.81 billion after underwriting discounts and expenses.
- 4The notes have staggered maturity dates from July 20, 2018, to July 20, 2045.
- 5Interest rates on the senior notes range from 1.900% to 5.125%.
- 6The offering was made pursuant to a Registration Statement on Form S-3, declared effective on July 2, 2015.
- 7Underwriters and their affiliates have engaged in prior and may engage in future transactions with CVS Health, including acting as financial advisor for past acquisitions.